Charnita Zeigler-Johnson

TitleAsst Professor
InstitutionThomas Jefferson University
DepartmentMedical Oncology
Address834 Chestnut Street
Philadelphia PA 19107
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Keith SW, Kwabi-Addo B, Zeigler-Johnson C. Interactions Between Obesity and One-Carbon Metabolism Genes in Predicting Prostate Cancer Outcomes Among White and Black Patients. J Racial Ethn Health Disparities. 2021 Jan 11. PMID: 33432479.
      Citations:    
    2. Dubey B, Jackson M, Zeigler-Johnson C, Devarajan K, Flores-Obando RE, McFarlane-Anderson N, Tulloch-Reid M, Aiken W, Kimbro K, Reed D, Kidd LR, Gibbs D, Kumar S, Ragin C. Interactive effect of TLR SNPs and exposure to sexually transmitted infections on prostate cancer risk in Jamaican men. Prostate. 2020 11; 80(15):1365-1372. PMID: 32894795.
      Citations:    
    3. Lake M, Shusted CS, Juon HS, McIntire RK, Zeigler-Johnson C, Evans NR, Kane GC, Barta JA. Black patients referred to a lung cancer screening program experience lower rates of screening and longer time to follow-up. BMC Cancer. 2020 Jun 16; 20(1):561. PMID: 32546140.
      Citations:    
    4. Giri VN, Knudsen KE, Kelly WK, Cheng HH, Cooney KA, Cookson MS, Dahut W, Weissman S, Soule HR, Petrylak DP, Dicker AP, AlDubayan SH, Toland AE, Pritchard CC, Pettaway CA, Daly MB, Mohler JL, Parsons JK, Carroll PR, Pilarski R, Blanco A, Woodson A, Rahm A, Taplin ME, Polascik TJ, Helfand BT, Hyatt C, Morgans AK, Feng F, Mullane M, Powers J, Concepcion R, Lin DW, Wender R, Mark JR, Costello A, Burnett AL, Sartor O, Isaacs WB, Xu J, Weitzel J, Andriole GL, Beltran H, Briganti A, Byrne L, Calvaresi A, Chandrasekar T, Chen DYT, Den RB, Dobi A, Crawford ED, Eastham J, Eggener S, Freedman ML, Garnick M, Gomella PT, Handley N, Hurwitz MD, Izes J, Karnes RJ, Lallas C, Languino L, Loeb S, Lopez AM, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann M, Mille P, Miner MM, Morgan T, Moreno J, Mucci L, Myers RE, Nielsen SM, O'Neil B, Pinover W, Pinto P, Poage W, Raj GV, Rebbeck TR, Ryan C, Sandler H, Schiewer M, Scott EMD, Szymaniak B, Tester W, Trabulsi EJ, Vapiwala N, Yu EY, Zeigler-Johnson C, Gomella LG. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019. J Clin Oncol. 2020 Jun 09; JCO2000046. PMID: 32516092.
      Citations:    
    5. Greidinger A, Miller-Samuel S, Giri VN, Woo MS, Akumalla S, Zeigler-Johnson C, Keith SW, Silver DP. Neuroendocrine Tumors Are Enriched in Cowden Syndrome. JCO Precis Oncol. 2020; 4. PMID: 32923874.
      Citations:    
    6. Zeigler-Johnson C, Keith S, McIntire R, Robinson T, Leader A, Glanz K. Racial and Ethnic Trends in Prostate Cancer Incidence and Mortality in Philadelphia, PA: an Observational Study. J Racial Ethn Health Disparities. 2018 Dec 05. PMID: 30520002.
      Citations:    
    7. Zeigler-Johnson C, Hudson A, Glanz K, Spangler E, Morales KH. Performance of prostate cancer recurrence nomograms by obesity status: a retrospective analysis of a radical prostatectomy cohort. BMC Cancer. 2018 Nov 03; 18(1):1061. PMID: 30390642.
      Citations:    
    8. Kurian CJ, Leader AE, Thong MSY, Keith SW, Zeigler-Johnson CM. Examining relationships between age at diagnosis and health-related quality of life outcomes in prostate cancer survivors. BMC Public Health. 2018 Aug 23; 18(1):1060. PMID: 30139347.
      Citations:    
    9. McIntire RK, Keith SW, Boamah M, Leader AE, Glanz K, Klassen AC, Zeigler-Johnson CM. A Prostate Cancer Composite Score to Identify High Burden Neighborhoods. Prev Med. 2018 Apr 04; 112:47-53. PMID: 29625131.
      Citations:    
    10. Dubey B, Jackson MD, Zeigler-Johnson C, Devarajan K, Flores-Obando RE, McFarlane-Anderson N, Tulloch-Reid MK, Aiken W, Kimbro K, Jones DZ, Kidd LR, Ragin C. Inflammation polymorphisms and prostate cancer risk in Jamaican men: Role of obesity/body size. Gene. 2017 Dec 15; 636:96-102. PMID: 28903065.
      Citations:    
    11. Lynch SM, Mitra N, Ross M, Newcomb C, Dailey K, Jackson T, Zeigler-Johnson CM, Riethman H, Branas CC, Rebbeck TR. A Neighborhood-Wide Association Study (NWAS): Example of prostate cancer aggressiveness. PLoS One. 2017; 12(3):e0174548. PMID: 28346484.
      Citations:    
    12. Zeigler-Johnson C, Morales KH, Lal P, Feldman M. The Relationship between Obesity, Prostate Tumor Infiltrating Lymphocytes and Macrophages, and Biochemical Failure. PLoS One. 2016; 11(8):e0159109. PMID: 27487262.
      Citations:    
    13. Yamoah K, Zeigler-Johnson CM, Jeffers A, Malkowicz B, Spangler E, Park JY, Whittemore A, Rebbeck TR. The impact of body mass index on treatment outcomes for patients with low-intermediate risk prostate cancer. BMC Cancer. 2016 Jul 29; 16:557. PMID: 27473687.
      Citations:    
    14. Myers RE, Leader AE, Censits JH, Trabulsi EJ, Keith SW, Petrich AM, Quinn AM, Den RB, Hurwitz MD, Lallas CD, Hegarty SE, Dicker AP, Zeigler-Johnson CM, Giri VN, Ayaz H, Gomella LG. Decision Support and Shared Decision Making About Active Surveillance Versus Active Treatment Among Men Diagnosed with Low-Risk Prostate Cancer: a Pilot Study. J Cancer Educ. 2016 Jul 15. PMID: 27418065.
      Citations:    
    15. Zeigler-Johnson C, Morales KH, Glanz K, Spangler E, Mitchell J, Rebbeck TR. Individual- and neighborhood-level education influences the effect of obesity on prostate cancer treatment failure after prostatectomy. Cancer Causes Control. 2015 Sep; 26(9):1329-37. PMID: 26169299.
      Citations:    
    16. Amin Al Olama A, Benlloch S, Antoniou AC, Giles GG, Severi G, Neal DE, Hamdy FC, Donovan JL, Muir K, Schleutker J, Henderson BE, Haiman CA, Schumacher FR, Pashayan N, Pharoah PD, Ostrander EA, Stanford JL, Batra J, Clements JA, Chambers SK, Weischer M, Nordestgaard BG, Ingles SA, Sorensen KD, Orntoft TF, Park JY, Cybulski C, Maier C, Doerk T, Dickinson JL, Cannon-Albright L, Brenner H, Rebbeck TR, Zeigler-Johnson C, Habuchi T, Thibodeau SN, Cooney KA, Chappuis PO, Hutter P, Kaneva RP, Foulkes WD, Zeegers MP, Lu YJ, Zhang HW, Stephenson R, Cox A, Southey MC, Spurdle AB, FitzGerald L, Leongamornlert D, Saunders E, Tymrakiewicz M, Guy M, Dadaev T, Little SJ, Govindasami K, Sawyer E, Wilkinson R, Herkommer K, Hopper JL, Lophatonanon A, Rinckleb AE, Kote-Jarai Z, Eeles RA, Easton DF. Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci. Cancer Epidemiol Biomarkers Prev. 2015 Jul; 24(7):1121-9. PMID: 25837820.
      Citations:    
    17. Yamoah K, Walker A, Spangler E, Zeigler-Johnson CM, Malkowicz B, Lee DI, Dicker AP, Rebbeck TR, Lal P. African-american race is a predictor of seminal vesicle invasion after radical prostatectomy. Clin Genitourin Cancer. 2015 Apr; 13(2):e65-72. PMID: 25450037.
      Citations:    
    18. Yamoah K, Deville C, Vapiwala N, Spangler E, Zeigler-Johnson CM, Malkowicz B, Lee DI, Kattan M, Dicker AP, Rebbeck TR. African American men with low-grade prostate cancer have increased disease recurrence after prostatectomy compared with Caucasian men. Urol Oncol. 2015 Feb; 33(2):70.e15-22. PMID: 25304288.
      Citations:    
    19. Zeigler-Johnson C, Morales KH, Spangler E, Chang BL, Rebbeck TR. Relationship of early-onset baldness to prostate cancer in African-American men. Cancer Epidemiol Biomarkers Prev. 2013 Apr; 22(4):589-96. PMID: 23532004.
      Citations:    
    20. Rebbeck TR, Devesa SS, Chang BL, Bunker CH, Cheng I, Cooney K, Eeles R, Fernandez P, Giri VN, Gueye SM, Haiman CA, Henderson BE, Heyns CF, Hu JJ, Ingles SA, Isaacs W, Jalloh M, John EM, Kibel AS, Kidd LR, Layne P, Leach RJ, Neslund-Dudas C, Okobia MN, Ostrander EA, Park JY, Patrick AL, Phelan CM, Ragin C, Roberts RA, Rybicki BA, Stanford JL, Strom S, Thompson IM, Witte J, Xu J, Yeboah E, Hsing AW, Zeigler-Johnson CM. Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of african descent. Prostate Cancer. 2013; 2013:560857. PMID: 23476788.
      Citations:    
    21. Rebbeck TR, Weber AL, Spangler E, Zeigler-Johnson CM. What stresses men? Predictors of perceived stress in a population-based multi-ethnic cross sectional cohort. BMC Public Health. 2013 Feb 06; 13:113. PMID: 23388399.
      Citations:    
    22. Zeigler-Johnson C, Weber A, Glanz K, Spangler E, Rebbeck TR. Gender- and ethnic-specific associations with obesity: individual and neighborhood-level factors. J Natl Med Assoc. 2013; 105(2):173-82. PMID: 24079218.
      Citations:    
    23. Fernandez P, Zeigler-Johnson CM, Spangler E, van der Merwe A, Jalloh M, Gueye SM, Rebbeck TR. Androgen Metabolism Gene Polymorphisms, Associations with Prostate Cancer Risk and Pathological Characteristics: A Comparative Analysis between South African and Senegalese Men. Prostate Cancer. 2012; 2012:798634. PMID: 23091730.
      Citations:    
    24. Zeigler-Johnson C, Weber A, Spangler E, Panossian S, Rebbeck TR, Malkowicz SB. Relationship of obesity, androgen receptor genotypes and biochemical failure after radical prostatectomy. Prostate. 2012 Jun 15; 72(9):984-90. PMID: 22025404.
      Citations:    
    25. Zeigler-Johnson CM, Tierney A, Rebbeck TR, Rundle A. Prostate cancer severity associations with neighborhood deprivation. Prostate Cancer. 2011; 2011:846263. PMID: 22111000.
      Citations:    
    26. Taioli E, Flores-Obando RE, Agalliu I, Blanchet P, Bunker CH, Ferrell RE, Jackson M, Kidd LC, Kolb S, Lavender NA, McFarlane-Anderson N, Morrison SS, Multigner L, Ostrande EA, Park JY, Patrick AL, Rebbeck TR, Romana M, Stanford JL, Ukoli F, Vancleave TT, Zeigler-Johnson CM, Mutetwa B, Ragin C. Multi-institutional prostate cancer study of genetic susceptibility in populations of African descent. Carcinogenesis. 2011 Sep; 32(9):1361-5. PMID: 21705483.
      Citations:    
    27. Haiman CA, Chen GK, Blot WJ, Strom SS, Berndt SI, Kittles RA, Rybicki BA, Isaacs WB, Ingles SA, Stanford JL, Diver WR, Witte JS, Hsing AW, Nemesure B, Rebbeck TR, Cooney KA, Xu J, Kibel AS, Hu JJ, John EM, Gueye SM, Watya S, Signorello LB, Hayes RB, Wang Z, Yeboah E, Tettey Y, Cai Q, Kolb S, Ostrander EA, Zeigler-Johnson C, Yamamura Y, Neslund-Dudas C, Haslag-Minoff J, Wu W, Thomas V, Allen GO, Murphy A, Chang BL, Zheng SL, Leske MC, Wu SY, Ray AM, Hennis AJ, Thun MJ, Carpten J, Casey G, Carter EN, Duarte ER, Xia LY, Sheng X, Wan P, Pooler LC, Cheng I, Monroe KR, Schumacher F, Le Marchand L, Kolonel LN, Chanock SJ, Van Den Berg D, Stram DO, Henderson BE. Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21. Nat Genet. 2011 Jun; 43(6):570-3. PMID: 21602798.
      Citations:    
    28. Barnholtz-Sloan JS, Guan X, Zeigler-Johnson C, Meropol NJ, Rebbeck TR. Decision tree-based modeling of androgen pathway genes and prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2011 Jun; 20(6):1146-55. PMID: 21493872.
      Citations:    
    29. Chang BL, Spangler E, Gallagher S, Haiman CA, Henderson B, Isaacs W, Benford ML, Kidd LR, Cooney K, Strom S, Ingles SA, Stern MC, Corral R, Joshi AD, Xu J, Giri VN, Rybicki B, Neslund-Dudas C, Kibel AS, Thompson IM, Leach RJ, Ostrander EA, Stanford JL, Witte J, Casey G, Eeles R, Hsing AW, Chanock S, Hu JJ, John EM, Park J, Stefflova K, Zeigler-Johnson C, Rebbeck TR. Validation of genome-wide prostate cancer associations in men of African descent. Cancer Epidemiol Biomarkers Prev. 2011 Jan; 20(1):23-32. PMID: 21071540.
      Citations:    
    30. Rebbeck TR, Weber AL, Walker AH, Stefflova K, Tran TV, Spangler E, Chang BL, Zeigler-Johnson CM. Context-dependent effects of genome-wide association study genotypes and macroenvironment on time to biochemical (prostate specific antigen) failure after prostatectomy. Cancer Epidemiol Biomarkers Prev. 2010 Sep; 19(9):2115-23. PMID: 20826827.
      Citations:    
    31. Anderson CA, Bellamy S, Figures M, Zeigler-Johnson C, Jalloh M, Spangler E, Coomes M, Gueye S, Rebbeck TR. Dietary intake of Senegalese adults. Nutr J. 2010 Feb 18; 9:7. PMID: 20167099.
      Citations:    
    32. Stefflova K, Dulik MC, Pai AA, Walker AH, Zeigler-Johnson CM, Gueye SM, Schurr TG, Rebbeck TR. Evaluation of group genetic ancestry of populations from Philadelphia and Dakar in the context of sex-biased admixture in the Americas. PLoS One. 2009 Nov 25; 4(11):e7842. PMID: 19946364.
      Citations:    
    33. Rebbeck TR, Rennert H, Walker AH, Panossian S, Tran T, Walker K, Spangler E, Patacsil-Coomes M, Sachdeva R, Wein AJ, Malkowicz SB, Zeigler-Johnson C. Joint effects of inflammation and androgen metabolism on prostate cancer severity. Int J Cancer. 2008 Sep 15; 123(6):1385-9. PMID: 18566991.
      Citations:    
    34. Tan YC, Zeigler-Johnson C, Mittal RD, Mandhani A, Mital B, Rebbeck TR, Rennert H. Common 8q24 sequence variations are associated with Asian Indian advanced prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2008 Sep; 17(9):2431-5. PMID: 18768513.
      Citations:    
    35. Zeigler-Johnson CM, Rennert H, Mittal RD, Jalloh M, Sachdeva R, Malkowicz SB, Mandhani A, Mittal B, Gueye SM, Rebbeck TR. Evaluation of prostate cancer characteristics in four populations worldwide. Can J Urol. 2008 Jun; 15(3):4056-64. PMID: 18570709.
      Citations:    
    36. Rennert H, Zeigler-Johnson C, Mittal RD, Tan YC, Sadowl CM, Edwards J, Finley MJ, Mandhani A, Mital B, Rebbeck TR. Analysis of the RNASEL/HPC1, and macrophage scavenger receptor 1 in Asian-Indian advanced prostate cancer. Urology. 2008 Aug; 72(2):456-60. PMID: 18436282.
      Citations:    
    37. Jalloh M, Zeigler-Johnson C, Sylla-Niang M, Niang L, Labou I, Konte KA, Rebbeck TR, Gueye S. A study of PSA values in an unselected sample of Senegalese men. Can J Urol. 2008 Feb; 15(1):3883-5. PMID: 18304398.
      Citations:    
    38. Zeigler-Johnson CM, Spangler E, Jalloh M, Gueye SM, Rennert H, Rebbeck TR. Genetic susceptibility to prostate cancer in men of African descent: implications for global disparities in incidence and outcomes. Can J Urol. 2008 Feb; 15(1):3872-82. PMID: 18304397.
      Citations:    
    39. Spangler E, Zeigler-Johnson CM, Coomes M, Malkowicz SB, Wein A, Rebbeck TR. Association of obesity with tumor characteristics and treatment failure of prostate cancer in African-American and European American men. J Urol. 2007 Nov; 178(5):1939-44; discussion 1945. PMID: 17868722.
      Citations:    
    40. Rennert H, Zeigler-Johnson CM, Addya K, Finley MJ, Walker AH, Spangler E, Leonard DG, Wein A, Malkowicz SB, Rebbeck TR. Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men. Cancer Epidemiol Biomarkers Prev. 2005 Apr; 14(4):949-57. PMID: 15824169.
      Citations:    
    41. Spangler E, Zeigler-Johnson CM, Malkowicz SB, Wein AJ, Rebbeck TR. Association of prostate cancer family history with histopathological and clinical characteristics of prostate tumors. Int J Cancer. 2005 Jan 20; 113(3):471-4. PMID: 15455347.
      Citations:    
    42. Zeigler-Johnson C, Friebel T, Walker AH, Wang Y, Spangler E, Panossian S, Patacsil M, Aplenc R, Wein AJ, Malkowicz SB, Rebbeck TR. CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer. Cancer Res. 2004 Nov 15; 64(22):8461-7. PMID: 15548719.
      Citations:    
    43. Zeigler-Johnson C, Panossian S, Gueye SM, Jalloh M, Ofori-Adjei D, Kanetsky PA. Population differences in the frequency of the agouti signaling protein g.8818a>G polymorphism. Pigment Cell Res. 2004 Apr; 17(2):185-7. PMID: 15016309.
      Citations:    
    44. Gueye SM, Zeigler-Johnson CM, Friebel T, Spangler E, Jalloh M, MacBride S, Malkowicz SB, Rebbeck TR. Clinical characteristics of prostate cancer in African Americans, American whites, and Senegalese men. Urology. 2003 May; 61(5):987-92. PMID: 12736021.
      Citations:    
    45. Zeigler-Johnson CM, Walker AH, Mancke B, Spangler E, Jalloh M, McBride S, Deitz A, Malkowicz SB, Ofori-Adjei D, Gueye SM, Rebbeck TR. Ethnic differences in the frequency of prostate cancer susceptibility alleles at SRD5A2 and CYP3A4. Hum Hered. 2002; 54(1):13-21. PMID: 12446983.
      Citations:    
    46. Zeigler-Johnson C. CYP3A4: a potential prostate cancer risk factor for high-risk groups. Clin J Oncol Nurs. 2001 Jul-Aug; 5(4):153-4. PMID: 12690615.
      Citations:    
    47. Rebbeck TR, Walker AH, Zeigler-Johnson C, Weisburg S, Martin AM, Nathanson KL, Wein AJ, Malkowicz SB. Association of HPC2/ELAC2 genotypes and prostate cancer. Am J Hum Genet. 2000 Oct; 67(4):1014-9. PMID: 10986046.
      Citations:    
    Zeigler-Johnson's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (159)
    Explore
    _
    Co-Authors (24)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _